Amisulpride Injection and Relugolix: Interaction Details

Brand names
Relugolix
Orgovyx
Amisulpride Injection
Barhemsys
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Amisulpride Injection and Relugolix interaction:

Share

Share this interaction

What Happens When You Take Amisulpride Injection With Relugolix

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Androgen deprivation produced by GnRH or has the potential to lengthen the , so giving relugolix together with drugs that prolong the QT interval results in effects on this interval. For patients with congenital long QT syndrome, congestive heart failure, or recurrent electrolyte disturbances, as well as for those receiving medications known to prolong the QT interval, it should be weighed whether the benefits of androgen deprivation therapy such as relugolix exceed its possible risks.1

Whenever feasible, relugolix should not be used concurrently with QT prolonging agents. When combined use cannot be avoided, drugs that induce electrolyte disturbances (ie, or ) should be avoided,2 any electrolyte abnormalities should be corrected, and periodic monitoring of electrolytes and ECGs should be considered.1

The Amisulpride Injection and Relugolix Interaction, Explained

Relugolix (Orgovyx) treats prostate cancer by lowering testosterone. Lower testosterone can slightly change the heart's electrical rhythm, something called the . Amisulpride (Barhemsys) is an IV medicine used around surgery to prevent or treat nausea and vomiting, and it can also lengthen the QT interval. Together, the effects may add up, which in rare cases could lead to a serious irregular heartbeat.

The good news: this risk is mostly theoretical, and amisulpride is usually given only briefly in a hospital setting. Let your care team know you take relugolix so they can check your heart and blood levels of potassium and magnesium and keep you safe.

Mechanism: . Androgen deprivation therapy (relugolix, oral GnRH ) may prolong QT; amisulpride (IV D2/D3 antagonist antiemetic) causes dose-dependent QTc prolongation. No interaction is implied.

Severity: Major. Evidence: Theoretical. Onset: Unspecified.

  • Avoid when possible; weigh benefit vs risk, especially with congenital long QT, CHF, or recurrent electrolyte disturbances.
  • If required: correct and beforehand and avoid other drugs that cause electrolyte depletion.
  • Consider baseline and periodic and electrolyte monitoring.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Amisulpride Injection and Relugolix Interact

The likely mechanism

In short: Amisulpride injection and relugolix both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Amisulpride Injection and Relugolix Interaction

Because both medicines can affect your heart rhythm, your care team will decide whether amisulpride is the best choice or whether another nausea medicine might fit better. If they use both, they may:

  • Check your potassium and magnesium levels and correct them if low
  • Avoid other medicines that can lower these minerals
  • Monitor your heart with an

What you can do: Keep taking relugolix as prescribed. Tell your surgical or hospital team that you take it, and mention any history of heart rhythm problems, heart failure, or fainting. Report palpitations, dizziness, or fainting right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Amisulpride Injection or Relugolix need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes

    A study of male patients on androgen deprivation therapy (ADT) used individual case safety reports from VigiBase, the international pharmacovigilance database, and identified 184 cases of acquired long-QT syndrome (aLQTS) and/or (TdP; 11% fatal cases), along with 99 cases of sudden death associated with ADT. The majority of ADT-associated aLQTS/TdP cases (62%) and sudden death cases (88%) arose without exposure to other drugs known to increase TdP risk; however, exposure to 1 drug and to 2 or more drugs with conditional, possible, or known TdP risk was reported in some aLQTS/TdP (23% or 43%) and sudden death (18% and 22%) events.

    The drugs classified as ADTs were abiraterone, gonadotropin-releasing hormone and , nonsteroidal androgen receptor indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism. Among the 10 ADTs assessed, 7 showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death, namely leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride.

    The median patient age was about 76 years, and the median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. ADT was given mainly for prostate cancer, with some patients receiving it for prostatism and androgenic alopecia. Most patients were receiving ADT monotherapy (83%), and 17% were receiving ADT combination therapy.3

Amisulpride Injection and Relugolix: Common Questions

How serious is the Amisulpride Injection and Relugolix interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Amisulpride Injection and Relugolix interaction managed?

Because both medicines can affect your heart rhythm, your care team will decide whether amisulpride is the best choice or whether another nausea medicine might fit better. If they use both, they may: Check your potassium and magnesium levels and correct them if low Avoid other medicines that can lower these minerals Monitor your heart with an What you can do: Keep taking relugolix as prescribe… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Amisulpride Injection and Relugolix Interaction

Ask in your own words about taking Amisulpride Injection and Relugolix together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: ORGOVYX oral tablets, relugolix oral tablets. Sumitomo Pharma America, Inc (per FDA), Marlborough, MA, 2025. DailyMed
  2. Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361.
  3. Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. PubMed
Was this write-up helpful?

Other Serious Interactions of Amisulpride Injection and Relugolix

Also serious with Relugolix

Also serious with Amisulpride Injection

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Relugolix

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.